DHA-enriched phosphatidylcholine suppressed angiogenesis by activating PPARγ and modulating the VEGFR2/Ras/ERK pathway in human umbilical vein endothelial cells

Phosphatidylserine from Portunus trituberculatus Eggs Alleviates Insulin Resistance and Alters the Gut Microbiota in High-Fat-Diet-Fed Mice

(2020) Shiwei Hu et al.   Marine Drugs

6-Gingerol stabilized the p-VEGFR2/VE-cadherin/β-catenin/actin complex promotes microvessel normalization and suppresses tumor progression

(2019) Weilong Zhong et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Fucoidan from Acaudina molpadioides improves insulin resistance by altering gut microbiota dysfunction

(2019) Shiwei Hu et al.   Journal of Functional Foods

New microtubulin inhibitor MT189 suppresses angiogenesis via the JNK-VEGF/VEGFR2 signaling axis

(2018) Lin Xu et al.   CANCER LETTERS

Eicosapentaenoic acid-enriched phospholipids improve atherosclerosis by mediating cholesterol metabolism

(2017) Lin Ding et al.   Journal of Functional Foods

ERK activation in endothelial cells is a novel marker during neovasculogenesis

(2016) Ayumi Nagasawa-Masuda et al.   GENES TO CELLS

Mechanisms and regulation of endothelial VEGF receptor signalling

(2016) Michael Simons et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

DHA blocks TPA-induced cell invasion by inhibiting MMP-9 expression via suppression of the PPAR-γ/NF-κB pathway in MCF-7 cells

(2016) Jin-Ki Hwang et al.   Oncology Letters

Omega-3 DHA- and EPA–dopamine conjugates induce PPARγ-dependent breast cancer cell death through autophagy and apoptosis

(2015) Daniela Rovito et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis

(2014) Fengyun Dong et al.   CANCER BIOLOGY & THERAPY

Computational model of VEGFR2 pathway to ERK activation and modulation through receptor trafficking

(2013) Wan Hua Tan et al.   CELLULAR SIGNALLING

The important roles of RET, VEGFR2 and the RAF/MEK/ERK pathway in cancer treatment with sorafenib

(2012) Wei-feng Mao et al.   ACTA PHARMACOLOGICA SINICA

The omega-3 polyunsaturated fatty acid eicosapentaenoic acid inhibits mouse MC-26 colorectal cancer cell liver metastasis via inhibition of PGE2-dependent cell motility

(2012) G Hawcroft et al.   BRITISH JOURNAL OF PHARMACOLOGY

Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases

(2012) M. Shibuya   JOURNAL OF BIOCHEMISTRY

Human amniotic glycodelin actively regulates changes in β-catenin immunoreactivity in cultured human umbilical vein endothelial cells (HUVEC)

(2012) Alessandro Pala et al.   Journal of Maternal-Fetal & Neonatal Medicine

Docosahexaenoic- and Eicosapentaenoic Acid-bound Lysophospholipids are More Effective in Suppressing Angiogenesis than Conjugated Docosahexaenoic Acid

(2012) Tadahiro Tsushima et al.   Journal of Oleo Science

Human Mesenchymal Stem Cells Inhibit Endothelial Proliferation and Angiogenesis via Cell–Cell Contact Through Modulation of the VE-Cadherin/β-Catenin Signaling Pathway

(2012) Tyler Menge et al.   STEM CELLS AND DEVELOPMENT

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

LIPID PROFILE AND FATTY ACID COMPOSITIONS IN BODY WALL OF APOSTICHOPUS JAPONICUS (SELENKA)

(2011) QIAO-MING LOU et al.   JOURNAL OF FOOD BIOCHEMISTRY

Ds-echinoside A, a new triterpene glycoside derived from sea cucumber, exhibits antimetastatic activity via the inhibition of NF-κB-dependent MMP-9 and VEGF expressions

(2011) Qin Zhao et al.   Journal of Zhejiang University-SCIENCE B

Anti-angiogenic action of PPARγ ligand in human umbilical vein endothelial cells is mediated by PTEN upregulation and VEGFR-2 downregulation

(2011) Ki Young Kim et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Molecular mechanisms and clinical applications of angiogenesis

(2011) Peter Carmeliet et al.   NATURE

Tumor angiogenesis: molecular pathways and therapeutic targets

(2011) Sara M Weis et al.   NATURE MEDICINE

The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential

(2009) Laura Spencer et al.   EUROPEAN JOURNAL OF CANCER

PPARγ ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis

(2008) Ahmad Aljada et al.   ANGIOGENESIS